Vascular Biogenics Correlations
| VBLTDelisted Stock | USD 0.16 0.01 5.88% |
The correlation of Vascular Biogenics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vascular Biogenics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vascular Biogenics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Vascular |
The ability to find closely correlated positions to Vascular Biogenics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vascular Biogenics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vascular Biogenics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vascular Biogenics to buy it.
Moving together with Vascular Stock
| + | 0.61 | MMM | 3M Company | Fiscal Quarter End 31st of December 2023 | PairCorr | |
| + | 0.69 | MRK | Merck Company | Fiscal Quarter End 31st of December 2023 | PairCorr | |
| + | 0.62 | CAT | Caterpillar | Fiscal Quarter End 31st of December 2023 | PairCorr |
Moving against Vascular Stock
| - | 0.49 | T | ATT Inc | Aggressive Push | PairCorr |
Related Correlations Analysis
PCAR | BWA | LEV | VC | CF | XFABF | AXL | AVNT | ||
PCAR | -0.62 | -0.48 | -0.48 | -0.51 | -0.19 | -0.11 | -0.09 | PCAR | |
BWA | -0.62 | 0.77 | 0.93 | 0.61 | 0.57 | 0.63 | 0.53 | BWA | |
LEV | -0.48 | 0.77 | 0.87 | 0.39 | 0.74 | 0.79 | 0.8 | LEV | |
VC | -0.48 | 0.93 | 0.87 | 0.55 | 0.7 | 0.78 | 0.71 | VC | |
CF | -0.51 | 0.61 | 0.39 | 0.55 | -0.03 | 0.16 | -0.02 | CF | |
XFABF | -0.19 | 0.57 | 0.74 | 0.7 | -0.03 | 0.82 | 0.87 | XFABF | |
AXL | -0.11 | 0.63 | 0.79 | 0.78 | 0.16 | 0.82 | 0.85 | AXL | |
AVNT | -0.09 | 0.53 | 0.8 | 0.71 | -0.02 | 0.87 | 0.85 | AVNT | |
PCAR | BWA | LEV | VC | CF | XFABF | AXL | AVNT |
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations | High negative correlations |
Risk-Adjusted Indicators
There is a big difference between Vascular Stock performing well and Vascular Biogenics company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vascular Biogenics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Information Ratio | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PCAR | 1.08 | 0.17 | 0.16 | 0.15 | 0.91 | 0.13 | (1.34) | 3.12 | (1.80) | 5.56 | |
| BWA | 1.46 | (0.25) | 0.00 | (0.49) | 0.00 | (0.12) | 0.00 | 2.92 | (2.63) | 16.20 | |
| LEV | 2.87 | (0.37) | 0.00 | (0.12) | 0.00 | (0.1) | 0.00 | 6.29 | (4.71) | 20.72 | |
| VC | 1.54 | (0.18) | 0.00 | (0.13) | 0.00 | (0.09) | 0.00 | 3.54 | (3.29) | 10.35 | |
| CF | 1.46 | 0.00 | 0.00 | 0.01 | 1.59 | (0.0022) | (1.81) | 3.58 | (3.14) | 9.64 | |
| XFABF | 1.17 | (0.16) | 0.00 | (0.20) | 0.00 | (0.0486) | 0.00 | 0.60 | (3.70) | 13.49 | |
| AXL | 1.83 | (0.04) | 0.00 | (0.01) | 0.00 | (0.0109) | 0.00 | 4.02 | (4.10) | 16.77 | |
| AVNT | 1.47 | (0.18) | 0.00 | (0.09) | 0.00 | (0.09) | 0.00 | 3.38 | (3.11) | 11.03 |
Delisting Warning - VBLT
Vascular Biogenics was delisted
| The entity Vascular Biogenics with a symbol VBLT was delisted from NASDAQ Exchange. Please try Notable Labs with a symbol NTBL from now on. Check all delisted instruments accross multiple markets. |
Vascular Biogenics Corporate Directors
Vascular Biogenics corporate directors refer to members of a Vascular Biogenics board of directors. The board of directors generally takes responsibility for the Vascular Biogenics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Vascular Biogenics' board members must vote for the resolution. The Vascular Biogenics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Philip Serlin | Non-Executive Independent Director | Profile | |
| Dan Gelvan | Non-Executive Independent Director | Profile | |
| Ron Cohen | Non-Executive Independent Director | Profile | |
| Ruth Alon | Non-Executive Independent Director | Profile |
Still Interested in Vascular Biogenics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |